Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer.
Tian S, Xu M, Geng X, Fang J, Xu H, Xue X, Hu H, Zhang Q, Yu D, Guo M, Zhang H, Lu J, Guo C, Wang Q, Liu S, Zhang W.
Tian S, et al. Among authors: zhang q, zhang w, zhang h.
Adv Sci (Weinh). 2025 Jan;12(1):e2410285. doi: 10.1002/advs.202410285. Epub 2024 Nov 5.
Adv Sci (Weinh). 2025.
PMID: 39499771
Free PMC article.